Literature DB >> 23530466

Pharmacovigilance: an active surveillance system to proactively identify risks for adverse events.

Christopher Moses, Leo A Celi, John Marshall.   

Abstract

Mesh：

Year:  2013        PMID： 23530466      PMCID： PMC5704747          DOI： 10.1089/pop.2012.0100

Source DB:  PubMed          Journal:  Popul Health Manag        ISSN： 1942-7891            Impact factor:   2.459


× No keyword cloud information.
  8 in total

1.  FDA advisory panel calls for suicide warnings over new antidepressants.

Authors:  Ray Moynihan
Journal:  BMJ       Date:  2004-02-07

2.  Azithromycin and the risk of cardiovascular death.

Authors:  Wayne A Ray; Katherine T Murray; Kathi Hall; Patrick G Arbogast; C Michael Stein
Journal:  N Engl J Med       Date:  2012-05-17       Impact factor: 91.245

3.  Adverse drug event surveillance and drug withdrawals in the United States, 1969-2002: the importance of reporting suspected reactions.

Authors:  Diane K Wysowski; Lynette Swartz
Journal:  Arch Intern Med       Date:  2005-06-27

4.  Analysis and recommendations for agency action regarding nonsteroidal antiinflammatory drugs and cardiovascular risk.

Authors: 
Journal:  J Pain Palliat Care Pharmacother       Date:  2005

5.  Multiparameter Intelligent Monitoring in Intensive Care II: a public-access intensive care unit database.

Authors:  Mohammed Saeed; Mauricio Villarroel; Andrew T Reisner; Gari Clifford; Li-Wei Lehman; George Moody; Thomas Heldt; Tin H Kyaw; Benjamin Moody; Roger G Mark
Journal:  Crit Care Med       Date:  2011-05       Impact factor: 7.598

6.  Long-term risk of cardiovascular events with rosiglitazone: a meta-analysis.

Authors:  Sonal Singh; Yoon K Loke; Curt D Furberg
Journal:  JAMA       Date:  2007-09-12       Impact factor: 56.272

7.  Risk of cardiovascular events and rofecoxib: cumulative meta-analysis.

Authors:  Peter Jüni; Linda Nartey; Stephan Reichenbach; Rebekka Sterchi; Paul A Dieppe; Matthias Egger
Journal:  Lancet       Date:  2004 Dec 4-10       Impact factor: 79.321

8.  Collective Experience: A Database-Fuelled, Inter-Disciplinary Team-Led Learning System.

Authors:  Leo A Celi; Roger G Mark; Joon Lee; Daniel J Scott; Trishan Panch
Journal:  J Comput Sci Eng       Date:  2012-03-01
  8 in total
  13 in total

1.  From Pharmacovigilance to Clinical Care Optimization.

Authors:  Leo Anthony Celi; Edward Moseley; Christopher Moses; Padhraig Ryan; Melek Somai; David Stone; Kai-Ou Tang
Journal:  Big Data       Date:  2014-09-01       Impact factor: 2.128

2.  "Big data" in the intensive care unit. Closing the data loop.

Authors:  Leo Anthony Celi; Roger G Mark; David J Stone; Robert A Montgomery
Journal:  Am J Respir Crit Care Med       Date:  2013-06-01       Impact factor: 21.405

3.  Feasibility of Representing Data from Published Nursing Research Using the OMOP Common Data Model.

Authors:  Hyeoneui Kim; Jeeyae Choi; Imho Jang; Jimmy Quach; Lucila Ohno-Machado
Journal:  AMIA Annu Symp Proc       Date:  2017-02-10

Review 4.  Active pharmacovigilance in China: recent development and future perspectives.

Authors:  Xinling Li; Haona Li; Jianxiong Deng; Feng Zhu; Ying Liu; Wenge Chen; Zhihua Yue; Xuequn Ren; Jielai Xia
Journal:  Eur J Clin Pharmacol       Date:  2018-04-10       Impact factor: 2.953

Review 5.  Improving postapproval drug safety surveillance: getting better information sooner.

Authors:  Sean Hennessy; Brian L Strom
Journal:  Annu Rev Pharmacol Toxicol       Date:  2014-09-25       Impact factor: 13.820

6.  Real-Life Active Surveillance of a Naphazoline/ Hypromellose Fixed Combination's Safety Profile in Peruvian Population.

Authors:  Homero Contreras-Salinas; Mariana Barajas-Hernández; Leopoldo Martín Baiza-Durán; Vanessa Orozco-Ceja; Lourdes Yolotzin Rodríguez-Herrera
Journal:  Integr Pharm Res Pract       Date:  2021-10-16

7.  Leveraging a critical care database: selective serotonin reuptake inhibitor use prior to ICU admission is associated with increased hospital mortality.

Authors:  Marzyeh Ghassemi; John Marshall; Nakul Singh; David J Stone; Leo Anthony Celi
Journal:  Chest       Date:  2014-04       Impact factor: 9.410

8.  US Food and Drug Administration utilization of postmarketing requirements and postmarketing commitments, 2009-2018.

Authors:  Joshua J Skydel; Audrey D Zhang; Sanket S Dhruva; Joseph S Ross; Joshua D Wallach
Journal:  Clin Trials       Date:  2021-04-16       Impact factor: 2.486

9.  Making big data useful for health care: a summary of the inaugural mit critical data conference.

Authors:  Omar Badawi; Thomas Brennan; Leo Anthony Celi; Mengling Feng; Marzyeh Ghassemi; Andrea Ippolito; Alistair Johnson; Roger G Mark; Louis Mayaud; George Moody; Christopher Moses; Tristan Naumann; Marco Pimentel; Tom J Pollard; Mauro Santos; David J Stone; Andrew Zimolzak
Journal:  JMIR Med Inform       Date:  2014-08-22

10.  Ophthalmic Solution Safety Profile: Active Surveillance of a Sodium Hyaluronate/Chondroitin Sulfate Combination in Peruvian Population.

Authors:  Homero Contreras-Salinas; Mariana Barajas-Hernández; Leopoldo Martín Baiza-Durán; Vanessa Orozco-Ceja; Lourdes Yolotzin Rodríguez-Herrera
Journal:  Drug Healthc Patient Saf       Date:  2021-05-27
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.